PLURISTEM THERAPEUTICS INC 4
4 · PLURISTEM THERAPEUTICS INC · Filed Sep 24, 2015
Insider Transaction Report
Form 4
BEN-YORAM ISRAEL
Director
Transactions
- Purchase
Common Stock
2015-09-21$2.14/sh+3,300$7,062→ 206,056 total - Purchase
Common Stock
2015-09-21$2.11/sh+3,900$8,229→ 202,756 total - Purchase
Common Stock
2015-09-21$2.08/sh+3,200$6,656→ 191,556 total - Purchase
Common Stock
2015-09-21$2.09/sh+100$209→ 191,656 total - Sale
Common Stock
2015-09-21$2.10/sh−30,000$63,000→ 176,056 total - Purchase
Common Stock
2015-09-21$2.07/sh+12,300$25,461→ 188,356 total - Purchase
Common Stock
2015-09-21$2.10/sh+7,200$15,120→ 198,856 total
Holdings
- 162,750(indirect: By Eshed Dash Ltd)
Common Stock
Footnotes (2)
- [F1]The reporting person's sale of 30,000 shares of PSTI common stock reported herein is matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's purchase of 30,000 shares of PSTI common stock reported herein. The reporting person has agreed to pay to PSTI, upon settlement of the sale, $323, representing the full amount of the profit realized in connection with the short-swing transaction.
- [F2]Private sale in New Israeli Shekels (NIS) for a per share price of NIS 8.12, which per share price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.863 per U.S. dollar.